Concept DHA

52747-0621-30 Rx only

Prenatal Multivitamin & Mineral Supplement capsules with Omega-3 fatty acids - DHA & EPA

Prenatal Multivitamin & Mineral Supplement capsules with Omega-3 fatty acids - DHA & EPA

Consult package literature for full prescription information.

You should contact your healthcare provider for medical advice about adverse events. To report a serious adverse event, contact US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036. Marketed by US Pharmaceutical Corporation.

Manufactured with Vcaps capsule shells.

Store at room temperature 15 degrees to 30 degrees C (59 degrees to 86 degrees F) and dry place.

Manufactured in a FDA registered facility in the USA.

Caution: Rx only.

Patent Numbers: USA: 5,626,883; Mexico MX/a/2008/004461; Singapore: 200802623-9 and other countries.

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Lift here for full prescription information

Indications: Concept DHA is a prenatal supplement designed to improve the nutritional status of women throughout pregnancy and during the postnatal period to lactating and non-lactating mothers. Concept DHA may also be used to improve the nutritional status of women before conception.

Contraindications: Concept DHA is contraindicated in patients with a known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. It is also contraindicated in patients suffering from pernicious anemia as folic acid may obscure its signs and symptoms.

Ferrous Fumarate and Polysaccharide Iron Compex (PIC): All Concept products include a unique patented source of iron, e.g. Ferrous Fumarate and Polysaccharide Iron Complex (U.S. Patent No: 11/243,043 pending).

"An increase in tolerability is observed with the formulation and is believed to occur as the result of distributing the total iron content in the composition among compounds that provide iron to the patient's blood stream via two different mechanisms. The ferrous salts are readily absorbed in the upper gut, by direct dissolution and absorption of the ferrous iron by the bloodstream. However, the iron available from PIC is absorbed in the lower gut, via an active protein transport mechanism"

Clinical Studies: Picinni, L.-Ricciotti, M. 1982. Therapeutic effectiveness of an iron-polysaccharide complex in comparison with iron fumarate in the treatment of iron deficiency anemias. PANMINERVA MEDICA-EUROPA MEDICA, Vol. 24, No. 3, pp.213-220 (July-September 1982).

Folic Acid: Folic Acid is one of the most important hematopoietic agents necessary for proper regeneration of the blood-forming elements and their function. Additionally, folic acid increases jejunal glycolytic enzymes and is involved in the desaturation and hydroxylation of long-chain fatty acids in the brain. A deficiency in folic acid results in megaloblastic anemia.

Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Precautions: Folic acid in doses above 0.1 mg - 0.4 mg daily may obscure the signs and symptoms of pernicious anemia, in the hematological remission can occur while neurological manifestations remain progressive. Overdose: Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300-mg/kg body weight.

When overdoses are ingested by children, severe reactions, including fatalities, have resulted.

Dosage and Administration: Adults (persons over 12 years of age), one (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage.

How supplied: Concept DHA are red maroon opaque Vcaps capsules printed in white with "Concept DHA" on the cap and "US" logo on the body. Packed in child-resistant cap and light resistant bottle of 30 capsules (52747-0621-30). The listed product number is not a National Drug Code. Instead, US Pharmaceutical Corporation has assigned this product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.

Packed in child-resistant cap and light resistant bottle of 30 capsules (52747-0621-30).

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Vcaps and the Vcaps Logo are trademarks used under license.